Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cobovit is a multivitamin and antioxidant combination product developed and marketed by ZRS Pharmaceuticals India Pvt. Ltd. The formulation typically contains methylcobalamin (1500 mcg), alpha-lipoic acid (100 mg), pyridoxine (3 mg), and folic acid (1.5 mg). It is primarily indicated for the management of peripheral neuropathy, diabetic neuropathy, and nutritional deficiencies. Methylcobalamin, a bioactive form of Vitamin B12, is essential for the synthesis of the myelin sheath and nerve regeneration. Alpha-lipoic acid acts as a potent antioxidant that scavenges free radicals and improves endoneurial blood flow, while pyridoxine and folic acid support metabolic processes critical for nerve health and DNA synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cobovit.